Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kyu-Sang Lim.
Herbal Formula Science | 2015
Jaecheol Lee; Myung Jung; Kyu-Sang Lim; Yong-Gab Yun
This report describes the remedial fields, symptoms, pathology, dosage, prescriptional constitution of 40 prescriptions related to the use of Magnoliae Cortex main blended prescriptions from Dongeuibogam. The following conclusions were reached through investigations on the prescriptions that use Magnoliae Cortex as a key component. Prescriptions that Magnoliae Cortex was taken as a monarch drug are utilized for 13 therapeutic purposes, for example, abdominal dropsy, abdominal lump. In particular, 27.5% of the prescriptions appear in the chapter of abdominal dropsy. Prescriptions that utilize Magnoliae Cortex as the main ingredient are used in the treatment of abdominal lump, abdominal dropsy. Magnoliae Cortex is used in pathogenic factors such as cold, congestion of Qi and used in pathology related to digestive system. The dosage of Magnoliae Cortex is 2pun(about 0.75g) to 3don(about 11.25 g), however 1don(about 3.75g) has been taken the most for clinical application. Pyeongwisan is the most useful base prescription which use the Magnoliae Cortex as the main component.
Herbal Formula Science | 2014
A-Ryoeng Jang; Jin-Ho Lee; Tae-hyun Kim; Dong-Hyun Kim; Hyung-Wook Choi; Myung Jung; Yong-Gab Yun; Kyu-Sang Lim
Objectives : Until now the study of Cnidii Rhizoma, hemorrhage, brain waves, such as ischemic brain injury, analgesic, effect overcome of the stress from pregnancy melanin formation and inhibiting effects skin whitening have been published regarding this article. Cnidii Rhizoma demonstrates its different abilities depending on the characteristics. This paper reported that effect of Cnidii Rhizoma in Dongeuibogam blended prescriptions as main medicine. In addition, by analyzing data, we studied about utilizing of Cnidii Rhizoma. Methods : Cnidii Rhizoma in Dongeuibogam Prescriptions as the main ingredient was built with database of 202 prescriptions. Thus analyzed data was summarized in detail.(Table-1) If there is no difference in the title of the prescription but in other case the configuration information is different, formulations 1 and 2 were divided by the table. Results : The following results were reached through investigations on the prescriptions usikng Cnidii Rhizoma as a key component. 1. Prescriptions taking Cnidii Rhizoma as a monarch drug are utilized for 40 therapeutic purposes. In particular, 12.3% of prescriptions appear in the chapter of head, and 10.8% of those appear in the chapter of women, and 9.4% of eye, 8.9% of child, 6.4% of wind disease respectively. 2. Prescriptions utilizing Cnidii Rhizoma as the main ingredient are used in the treatment of headache, dizziness and pregnancy hemorrhage fetal movement, premature birth and they are also used for treating 131 different types of disease. 3. The dosage of Cnidii Rhizoma in formulas is from 2pun(about 0.75g) to 5don(nearly 18.75g), however 1don(nearly 3.75g) has been taken the most for clinical application. 4. We find out that according to herbs or prescriptions, Cnidii Rhizoma has a variety of functions such as ascending & descending of energy. Samultang is the most useful base prescription which used the Cnidii Rhizoma as the main component. Conclusion : These results suggest that, Cnidii Rhizoma once-amount use (don nearly 3.75g) 4g in head, gynecology, ophthalmology, pediatrics and paralysis disease associated with oriental medicine resource development can be considered to be widely used These results suggest that Cnidii Rhizoma was used most with 1 don(4g) and can be widely used for the resource development to the disease such as brain, gynecology, ophthalmologhy, pediatrics and wind-associated symptoms.
The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology | 2011
Dae-Sung Kim; Byung-Gon Sung; Jang-Cheon Lee; Boo-Kyun Lee; Won-Hong Woo; Kyu-Sang Lim
The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology | 2015
Sang-Hyun Lee; Myung Jung; Kyu-Sang Lim; Yong-Gab Yun
The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology | 2009
Sung-Jin Lee; Dae-Sung Kim; Yeun-Ja Mun; Won-Hong Woo; Jang-Cheon Lee; Kyu-Sang Lim
The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology | 2000
Byung-Gon Sung; Chun-Keun Oh; Kyu-Sang Lim
The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology | 2015
Jin-Ho Lee; Myung-Hee In; Suk-Hoon Kang; Yeun-Ja Mun; Won-Hong Woo; Kyu-Sang Lim
The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology | 2014
Yeun-Ja Mun; Byoung-Kook Jeon; Tae-Hyun Kim; Jin-Ho Lee; Hyung-Wook Choi; Kyu-Sang Lim; Won-Hong Woo
The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology | 2011
Tae-Hyun Kim; Pom-Ho Kim; Byoung-Kook Jeon; Jeong-Rock Yoon; Won-Hong Woo; Yeun-Ja Mun; Jang-Cheon Lee; Boo-Kyun Lee; oung-Gue Park; Kyu-Sang Lim
The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology | 2010
Kyu-Sang Lim; Jang-Cheon Lee; Young-Gue Park